DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Pirenperone
Pirenperone
Upregulation of Peroxisome Proliferator-Activated Receptor-Α And
S1 Figa
Perception of Naturally Dead Conspecifics Impairs Health and Longevity
(12) Patent Application Publication (10) Pub. No.: US 2010/0304998 A1 Sem (43) Pub
Sex Differences in Serotonergic and Dopaminergic Mediation of LSD Discrimination in Rats
Discriminative Stimulus Properties of Lysergic Acid Diethylamide in the Monkey
The Effect of Ketanserin and Pirenperone Injected Into the CA1 Region on Spatial Discrimination
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
Given These Low Odds, It Is Far More Reasonable to Expect the Person Of
Behavioral Pharmacology of Dopamine D2 and D3 Receptor Agonists and Antagonists in Rats
Stembook 2018.Pdf
(12) Patent Application Publication (10) Pub. No.: US 2009/0076019 A1 Tyers Et Al
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
Drug Discrimination: Applications to Drug Abuse Research
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Top View
(12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
A Drug Discrimination Analysis of Lysergic Acid Diethylamide (LSD
List of Common Prohibited Substance for the California Equine Medication
Discriminative Stimulus Effects of 3,4-Methylenedioxypyrovalerone (MDPV) and Structurally Related Synthetic Cathinones
Lysophosphatidic Acid Receptor Agonism: Discovery of Potent Nonlipid Benzofuran Ethanolamine Structures S
Pharmaabkommen A1 E
Serotonergic-Dopaminergic Mediation of -Ties Yof 3 4-Methylenedioxymethamphetamine Mid Nistre (MDMA, "Ecstasy") Ail T of )F a MARTIND
Example List of Forbidden Substances
Customs Tariff - Schedule Xxi - 1
Wo 2007/044693 A2
Multi-Parametric Profiling of Endothelial Cell Networks Reveals Functional Role of Glutamate Receptors in Angiogenesis
Drugs and Medications
The Behavioral Pharmacology of Hallucinogens William E
A Small Molecule Drug Screening Identifies Colistin Sulfate As an Enhancer of Natural Killer
2020 AQHA Guidelines and Rules for Drugs and Medications
Known Bioactives Library: Prestwick 2 Collection
Sleep Apnea and CMV Driver Safety
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Supplementary Material
(12) Patent Application Publication (10) Pub. No.: US 2009/0325975 A1 Buschmann (43) Pub
AERC Drug Rule Appendices
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
1111111111111111111Imnumu
Antipsychotics for Treatment of Delirium in Hospitalised Non-ICU Patients
Assessment of Dopaminergic and Serotonergic Receptor Antagonists in Male Rats Trained to Discriminate 4-Methylmethcathinone (Mephedrone)
Monograph Series
5-HT Inhibits Spontaneous Contractility of Isolated Sheep Mesenteric Lymphatics Via Activation
Download Program
Molecular Targets of Psychedelics and Their Role in Behavioral Models of Hallucinogenic Action
Known Bioactive Library: LOPAC 1